Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma

Shivani Dixit1, Agnes Y Choi1, Anand Singh1

  • 1Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Journal of Cancer Metastasis and Treatment
|June 16, 2023
PubMed

Insights

Malignant pleural mesothelioma (MPM) is a challenging cancer. Re-expressing specific tumor suppressor microRNAs (miRNAs) offers a promising therapeutic strategy by targeting key gene networks involved in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited treatment options.
  • MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression and are often dysregulated in cancer.
  • Tumor suppressor miRNAs are frequently underexpressed in cancers, including MPM.

Purpose of the Study:

  • To review promising tumor suppressor miRNAs specific to MPM.
  • To explore their potential as novel therapeutic agents.
  • To summarize supporting data and known molecular mechanisms.

Main Methods:

  • Literature review of studies on miRNAs in MPM.
  • Analysis of miRNA dysregulation in MPM pathophysiology.
  • Identification of MPM-specific tumor suppressor miRNAs.

Main Results:

  • Several tumor suppressor miRNAs show potential for MPM therapy.
  • Dysregulation of these miRNAs is linked to MPM development.
  • Understanding their molecular mechanisms is crucial for therapeutic development.

Conclusions:

  • Re-expressing tumor suppressor miRNAs is a viable therapeutic strategy for MPM.
  • Targeting specific miRNAs could overcome treatment resistance in MPM.
  • Further research into MPM-specific miRNAs may lead to new treatments.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
250